The Rise of "Off-the-Shelf" Cures: Allogeneic Gene Editing in 2025
One of the biggest hurdles in gene therapy has always been its "bespoke" nature—the need to use a patient's own cells for every treatment. However, 2025 marks the emergence of "allogeneic" or "off-the-shelf" gene-edited therapies. By using CRISPR to remove the proteins that cause immune rejection, scientists can now create master cell lines from healthy donors that can be safely infused...
0 Kommentare 0 Geteilt 58 Ansichten 0 Bewertungen